Pieris Pharmaceuticals, Inc. has appointed Allan Reine as Senior Vice President and Chief Financial Officer, effective August 9, 2017. Dr. Reine is an accomplished healthcare investor and brings to Pieris a wealth of capital markets experience, a deep biotech background, and a strong scientific acumen. Prior to joining Pieris, from 2012 through August 2017, Dr. Reine was a portfolio manager at Lombard Odier Asset Management, where he ran a healthcare portfolio focused on biotechnology and pharmaceutical companies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.235 USD | -4.79% | -10.82% | -36.57% |
1st Jan change | Capi. | |
---|---|---|
-36.57% | 12.19M | |
+14.84% | 121B | |
+18.31% | 112B | |
+3.41% | 22.57B | |
-18.26% | 20.82B | |
-18.14% | 16.19B | |
-42.36% | 16.17B | |
-14.23% | 16.3B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- PIRS Stock
- News Pieris Pharmaceuticals, Inc.
- Pieris Pharmaceuticals, Inc. Appoints Allan Reine as Senior Vice President and Chief Financial Officer